Literature DB >> 29936103

Synergistic cytokine effects as apremilast response predictors in patients with psoriasis.

Sandra Garcet1, Kristine Nograles2, Joel Correa da Rosa1, Peter H Schafer3, James G Krueger4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29936103     DOI： 10.1016/j.jaci.2018.05.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Population pharmacokinetic and exposure-response analysis of apremilast in Japanese subjects with moderate to severe psoriasis.

Authors:  Yukari Okubo; Mamitaro Ohtsuki; Mayumi Komine; Shinichi Imafuku; Nastya Kassir; Rosemary Petric; Osamu Nemoto
Journal:  J Dermatol       Date:  2021-08-15       Impact factor: 3.468

2.  Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.

Authors:  Kristina Navrazhina; John W Frew; David Grand; Samuel C Williams; Hong Hur; Juana Gonzalez; Sandra Garcet; James G Krueger
Journal:  Br J Dermatol       Date:  2022-06-02       Impact factor: 11.113

3.  Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients.

Authors:  Sophie E Berends; Tamara J van Steeg; Maurice J Ahsman; Sharat Singh; Johannan F Brandse; Geert R A M D'Haens; Ron A A Mathôt
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-09-05       Impact factor: 2.745

4.  Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial.

Authors:  Shinichi Imafuku; Osamu Nemoto; Yukari Okubo; Mayumi Komine; Peter Schafer; Rosemary Petric; Mamitaro Ohtsuki
Journal:  J Dermatol       Date:  2020-09-10       Impact factor: 4.005

5.  Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.

Authors:  Steven A Saenz; Andrea Local; Tiffany Carr; Arvind Shakya; Shivsmriti Koul; Haiqing Hu; Lisa Chourb; Justin Stedman; Jenna Malley; Laura Akullian D'Agostino; Veerabahu Shanmugasundaram; John Malona; C Eric Schwartz; Lisa Beebe; Meghan Clements; Ganesh Rajaraman; John Cho; Lan Jiang; Alex Dubrovskiy; Matt Kreilein; Roman Shimanovich; Lawrence G Hamann; Laure Escoubet; J Michael Ellis
Journal:  PLoS One       Date:  2021-11-09       Impact factor: 3.240

6.  Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.

Authors:  A R J V Vossen; H H van der Zee; N Davelaar; A M C Mus; M B A van Doorn; E P Prens
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-12-10       Impact factor: 6.166

7.  The Effect of Janus Kinase Inhibitors and Phosphodiesterase-4 Inhibitors on Skin and Plasma Cytokine Levels in Patients with Psoriasis.

Authors:  O G Artamonova; A E Karamova; A A Nikonorov; D A Verbenko; E L Vasileva; A A Kubanov
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.